Skip to main content
Premium Trial:

Request an Annual Quote

BioServe to Use Seegene's Tests to Detect STDs, TB in India

NEW YORK (GenomeWeb News) - BioServe said today that it has inked a partnership with Seegene to develop a detection system to diagnose a number of infectious diseases in India, BioServe said today.
Seegene, which is based in Seoul and maintains a US headquarters in Rockville, Md., will access BioServe's repository of Indian DNA samples to collaborate on development of a test for several sexually transmitted diseases, tuberculosis, and HIV-1 and HIV-2, BioServe said.
BioServe, which retains research and production facilities in Hyberabad, India, will use Seegene's Seeplex STD detection system to test for Mycoplasma hominis, Ureaplasma urealyticum, Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus 2, and human papillomavirus. The assay also will test for tuberculosis, which BioServe said.
BioServe cited a World Health Organization estimate that India sees roughly 1.8 million new cases of TB each year. BioServe also said there are more than 5.1 million Indians currently infected with HIV. 
The test is based on Seegene's dual priming oligonucleotide technology, which is a DNA amplification method that can be used in simultaneous multi-pathogen detection assays, BioServe said.
Specific financial terms of the agreement were not released.
Jessica Joung, manager of Seegene's Rockville branch, told GenomeWeb Daily News today that the two companies plan to evaluate the collaboration at the end of 2007, and decide at that time whether to extend the agreement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.